Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
ALF funds for clinical research through Region Uppsala
Cancerfonden (2020 1303 PjF 01 H)
Cancerfonden (HA)
Uppsala University
- License Information
-
More Information
Article History
Received: 13 February 2023
Accepted: 18 June 2023
First Online: 12 July 2023
Declarations
:
: Håkan Ahlström is a co-founder and part-time employee of Antaros Medical AB, Mölndal, Sweden.
: This article does not contain any studies with human participants or animals performed by any of the authors. Since only phantom trials were performed, no institutional review board (IRB) approval was required.
: Informed consent is not required for this type of study.
: Consent for publication is not required for this type of study.
